SBP have just announced the appointment of Professor John Papadimitriou as a director . This has to be seen as step in the right direction for the proper management of what is a company with a huge potential in the bio tech field . Despite recent good annnouncements regarding trial work the share price is well below its potential. Especially SBPOA which offers great leverage.
SBP
solbec pharmaceuticals limited
SBP have just announced the appointment of Professor John...
Add to My Watchlist
What is My Watchlist?